Less Ads, More Data, More Tools Register for FREE

Pin to quick picksFCAP.L Regulatory News (FCAP)

  • There is currently no data for FCAP

Form 8 (OPD) - finnCap Group plc

1 Nov 2022 11:02

RNS Number : 9145E
Panmure Gordon Group Limited
01 November 2022
 

FORM 8 (OPD)

 

PUBLIC OPENING POSITION DISCLOSURE BY A PARTY TO AN OFFER

Rules 8.1 and 8.2 of the Takeover Code (the "Code")

 

1. KEY INFORMATION

 

(a) Full name of discloser:

Panmure Gordon Group Limited

(b) Owner or controller of interests and short positions disclosed, if different from 1(a):

The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.

(c) Name of offeror/offeree in relation to whose relevant securities this form relates:

Use a separate form for each offeror/offeree

finnCap Group plc

(d) Is the discloser the offeror or the offeree?

OFFEROR

(e) Date position held:

The latest practicable date prior to the disclosure

31 October 2022

(f) In addition to the company in 1(c) above, is the discloser making disclosures in respect of any other party to the offer?

If it is a cash offer or possible cash offer, state "N/A"

YES

Panmure Gordon Group Limited

 

2. POSITIONS OF THE PARTY TO THE OFFER MAKING THE DISCLOSURE

 

If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

 

(a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates

 

Class of relevant security:

 

Ordinary shares of 1p each

 

 

Interests

Short positions

Number

%

Number

%

(1) Relevant securities owned and/or controlled:

Nil

 

Nil

 

(2) Cash-settled derivatives:

 

Nil

 

Nil

 

(3) Stock-settled derivatives (including options) and agreements to purchase/sell:

Nil

 

Nil

 

 

TOTAL:

Nil

 

Nil

 

 

All interests and all short positions should be disclosed.

 

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

 

Details of any securities borrowing and lending positions or financial collateral arrangements should be disclosed on a Supplemental Form 8 (SBL).

 

(b) Rights to subscribe for new securities

 

Class of relevant security in relation to which subscription right exists:

Nil

Details, including nature of the rights concerned and relevant percentages:

Nil

 

 

3. POSITIONS OF PERSONS ACTING IN CONCERT WITH THE PARTY TO THE OFFER MAKING THE DISCLOSURE

 

Details of any interests, short positions and rights to subscribe (including directors' and other employee options) of any person acting in concert with the party to the offer making the disclosure:

None

 

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

 

Details of any securities borrowing and lending positions or financial collateral arrangements should be disclosed on a Supplemental Form 8 (SBL).

 

4. OTHER INFORMATION

 

(a) Indemnity and other dealing arrangements

 

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the party to the offer making the disclosure or any person acting in concert with it:

Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state "none"

 

None

 

 

(b) Agreements, arrangements or understandings relating to options or derivatives

 

Details of any agreement, arrangement or understanding, formal or informal, between the party to the offer making the disclosure, or any person acting in concert with it, and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state "none"

 

None

 

 

(c) Attachments

 

Are any Supplemental Forms attached?

 

Supplemental Form 8 (Open Positions)

NO

Supplemental Form 8 (SBL)

NO

 

 

Date of disclosure:

1 November 2022

Contact name:

Barry Wainwright

Telephone number:

020 7886 2500

 

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service.

 

The Panel's Market Surveillance Unit is available for consultation in relation to the Code's disclosure requirements on +44 (0)20 7638 0129.

 

The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
FEEBKDBKDBDDKDK
Date   Source Headline
19th Oct 20227:15 amRNSRule 2.9 Announcement
18th Oct 20222:58 pmEQSForm 8.3 - Maitland Institutional Services Limited: Re finnCap plc
18th Oct 20227:00 amRNSResponse to offer speculation
3rd Oct 20227:00 amRNSTotal Voting Rights
28th Sep 20227:00 amRNSDirectorate Change
15th Sep 202211:16 amRNSResult of AGM
15th Sep 20227:00 amRNSAGM Trading Update
1st Sep 20227:00 amRNSCEO Transition Completed
1st Sep 20227:00 amRNSTotal Voting Rights
5th Aug 20227:00 amRNSDividend Declaration, Annual Report & AGM Notice
1st Aug 20227:00 amRNSTotal Voting Rights
14th Jul 20227:00 amRNSResults for year ended 31 March 2022
8th Jul 20227:00 amRNSAppointment of Executive Directors
1st Jul 20227:00 amRNSTotal Voting Rights
21st Jun 20227:00 amRNSProposed New CEO and appointment of new Directors
1st Jun 20227:00 amRNSBlock Admission Return and Total Voting Rights
16th May 20227:00 amRNSDirectorate Change
29th Apr 20227:00 amRNSTotal Voting Rights
28th Apr 20227:00 amRNSBuilding a leading advisory business
14th Apr 20227:23 amRNSFY22 Unaudited Revenue
1st Apr 20227:00 amRNSTotal Voting Rights
10th Mar 20227:00 amRNSTrading Update
1st Mar 20227:00 amRNSTotal Voting Rights
8th Feb 20229:18 amRNSDirector Dealing
1st Feb 20227:00 amRNSTotal Voting Rights
28th Jan 202210:22 amRNSHolding(s) in Company
28th Jan 202210:21 amRNSHolding(s) in Company
26th Jan 20227:00 amRNSOption Exercise, Dealing Amendment and TVR
25th Jan 20227:00 amRNSAppointment of Non-Executive Director
31st Dec 20217:00 amRNSTotal Voting Rights
9th Dec 20215:25 pmRNSHolding(s) in Company
8th Dec 20214:04 pmRNSCOVID Option Exercises and EBT Holdings in Company
1st Dec 20217:00 amRNSBlock Admission Return and Total Voting Rights
18th Nov 20217:00 amRNSInterim Results and Dividend
2nd Nov 20217:00 amRNSNotice of Interims and Investor Presentation
1st Nov 20217:00 amRNSTotal Voting Rights
19th Oct 202111:01 amRNSHolding(s) in Company
4th Oct 20217:00 amRNSH1 22 Unaudited Revenues – strong growth on H1 21
1st Oct 20217:00 amRNSTotal Voting Rights
24th Sep 20217:00 amRNSExercise of Options and Total Voting Rights
23rd Sep 202111:21 amRNSResult of AGM
23rd Sep 20217:00 amRNSAGM Trading Statement
15th Sep 20219:51 amRNSAGM Update
1st Sep 20217:00 amRNSTotal Voting Rights
30th Jul 20217:00 amRNSTotal Voting Rights
22nd Jul 20217:00 amRNSSecond Interim Dividend
7th Jul 202110:00 amRNSAnnual Report and Annual General Meeting Notice
6th Jul 20217:00 amRNSDirector Dealing, Option Exercise and TVR
1st Jul 20217:00 amRNSPreliminary results - year ended 31 March 2021
1st Jul 20217:00 amRNSTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.